U.S. Genetic Testing Market Industry Outlook, Share, and Forecast 2027

The U.S. genetic testing market size in 2026 has witnessed significant transformation over the past decade, driven by technological advancements, rising awareness regarding personalized medicine, and increasing demand for early disease diagnosis. Genetic testing plays a crucial role in identifying inherited conditions, assessing disease risks, and guiding treatment decisions, thereby contributing to improved patient outcomes.

According to Fortune Business Insights, the U.S. genetic testing market size was valued at USD 4.11 billion in 2019. The outbreak of COVID-19 had an unprecedented and staggering impact on the market, resulting in a temporary decline in demand due to disruptions in healthcare services and reduced patient visits. Based on analysis, the market exhibited a lower growth rate of 6.7% in 2020 compared to the average year-on-year growth observed during 2016-2019.

Despite the short-term slowdown, the market demonstrated resilience and is projected to grow from USD 4.38 billion in 2020 to USD 10.29 billion by 2027, exhibiting a strong CAGR of 13.0% during the forecast period. The long-term outlook remains highly positive, supported by increasing investments in genomics research and expanding clinical applications.

Growing Importance of Genetic Testing in Healthcare

Genetic testing has become an essential component of modern healthcare systems in the United States. It enables healthcare professionals to detect genetic mutations, predict disease susceptibility, and customize treatment strategies. The growing adoption of precision medicine has significantly accelerated the demand for genetic testing services across the country.

Additionally, the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and rare genetic conditions has increased the need for advanced diagnostic solutions. Genetic testing helps in early detection and prevention, which ultimately reduces healthcare costs and improves patient survival rates.

Market Drivers & Restraints:

Drivers:

• Rising demand for personalized and precision medicine

• Increasing prevalence of genetic and chronic diseases

• Advancements in next-generation sequencing technologies

• Growing awareness regarding early disease detection

• Expansion of direct-to-consumer genetic testing services

Restraints:

• High cost associated with advanced genetic tests

• Ethical and privacy concerns related to genetic data

• Limited reimbursement policies in certain cases

• Lack of skilled professionals in genetic counseling

Market Report Coverage:

The U.S. genetic testing market report provides comprehensive insights into key market trends, growth drivers, challenges, and opportunities. It includes detailed analysis of market segments, competitive landscape, technological advancements, and regulatory framework. The report also highlights the impact of COVID-19 on market dynamics and future growth prospects.

Market Competitive Landscape:

The market is highly competitive, with several established players focusing on strategic initiatives such as mergers, acquisitions, partnerships, and product innovations to strengthen their market position. Companies are also investing heavily in research and development to enhance their genetic testing capabilities and expand their service offerings.

Top Companies In The

• Invitae Corporation (San Francisco, U.S.)

• Ambry Genetics (Aliso Viejo, U.S.)

• BioReference Laboratories, Inc. (Elmwood Park, U.S.)

• Progenity, Inc. (San Diego, U.S.)

• Quest Diagnostics Incorporated (Secaucus, U.S.)

• Myriad Genetics, Inc. (Salt Lake City, U.S.)

• Fulgent Genetics (Temple City, U.S.)

• Burning Rock Biotech Limited (Guangzhou, China)

Market Segments:

The U.S. genetic testing market is segmented based on type, technology, application, and end-user. Each segment plays a vital role in shaping the overall market landscape.

By Technique (PCR, DNA Sequencing, Microarrays, and Others)

By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, and Others)

By Payer (Public Health Insurance, Private Health Insurance, and Out-of-Pocket)

By End-User (Hospitals, and Independent Laboratories)

Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034 

Market Regional Insights:

The United States dominates the genetic testing market due to its advanced healthcare infrastructure, high adoption of innovative technologies, and strong presence of leading market players. The country also benefits from favorable government initiatives and increased funding for genomics research.

Moreover, the rising awareness among the population regarding genetic disorders and preventive healthcare has significantly contributed to market growth across various regions within the U.S.

Future Market Scope:

The future of the U.S. genetic testing market looks promising, with continuous advancements in genomic technologies and increasing integration of artificial intelligence in genetic analysis. The expansion of personalized medicine and growing demand for targeted therapies are expected to drive market growth further.

Additionally, the development of cost-effective testing solutions and improved accessibility to genetic services will create new opportunities for market expansion. The increasing focus on early diagnosis and preventive healthcare will continue to support the long-term growth of the market.

April 2021 – Invitae Corporation announced that their sponsored genetic testing is available for patients at risk of developing some common adult neurodegenerative conditions in the region of U.S., Canada, Australia and Brazil. This availability of this program will be free of cost and will help at-risk individuals having difficult to diagnose conditions

Conclusion

In conclusion, the U.S. genetic testing market is set to experience robust growth in the coming years, driven by technological advancements, increasing disease prevalence, and rising demand for personalized healthcare solutions. Despite the temporary setbacks caused by the COVID-19 pandemic, the market has demonstrated strong recovery and resilience. With continuous innovation and expanding applications, genetic testing is expected to play a pivotal role in transforming the future of healthcare in the United States.

Contact us:Fortune Business Insights™ Pvt.Phone: USA: +1 833 909 2966 (Toll-Free),United Kingdom: +44 808 502 0280 (Toll-Free),APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.com